Semaglutide at Home in Madrid: How the Metabolic Care Programme Works
If you live in Madrid or anywhere else in Spain and are looking for medically supervised GLP-1 treatment for weight management, understanding how a serious, comprehensive programme works can make the difference between a supported process and another unsuccessful attempt.
In this article, we explain how DomoMed Salud’s Metabolic Care programme works, what it includes, why we carry out a cardiometabolic assessment before starting treatment and how, with the patient’s authorisation, we can coordinate communication with a partner pharmacy to facilitate access to the prescribed medication.
What Is Semaglutide and Why Is It Used for Weight Management?
Semaglutide is a glucagon-like peptide-1 receptor agonist, commonly known as a GLP-1 receptor agonist.
It belongs to a class of medications that act on biological mechanisms related to appetite, satiety and glucose metabolism.
At a dose of 2.4 mg once weekly, semaglutide is authorised in Europe under the brand name Wegovy for the medical treatment of obesity in adults. It must always be used alongside a reduced-calorie diet and increased physical activity.
Its mechanism of action includes:
Reducing appetite through its effects on the central nervous system.
Delaying gastric emptying, which prolongs the feeling of fullness.
Improving glucose-dependent insulin secretion.
In the STEP clinical trial programme, semaglutide 2.4 mg produced clinically meaningful average weight reductions in patients with obesity or overweight and associated health conditions.
Beyond weight loss, certain patients with obesity and established cardiovascular disease may obtain additional benefits in terms of reduced cardiovascular events.
These potential benefits must always be assessed individually according to each patient’s clinical characteristics.
What Is the Metabolic Care Programme?
Metabolic Care is DomoMed Salud’s medical programme for patients with obesity or overweight associated with cardiometabolic risk factors who wish to begin pharmacological weight-management treatment with complete medical supervision, convenience and close follow-up.
The programme is designed for patients seeking more than a prescription.
It includes:
An initial clinical assessment.
An individualised medical plan.
Support throughout treatment.
Practical coordination to make the process easier.
The programme is available in two formats.
Metabolic Care at Home in Madrid
The in-person home programme is available in Madrid and the surrounding metropolitan area.
It includes:
A medical consultation at the patient’s home.
A complete clinical assessment.
A 12-lead electrocardiogram.
An ECG report prepared by a cardiology specialist.
Online Metabolic Care Throughout Spain
The online programme is available to patients throughout Spain and is delivered through video consultations.
Both options include:
Clinical assessment.
Review of blood test results.
Assessment of whether pharmacological treatment is indicated.
Prescription when appropriate.
A complete medical report.
Monthly follow-up for three months to assess progress, treatment tolerance and goals.
Why Do We Perform an ECG Before Starting Treatment?
An ECG is not a universal mandatory requirement before starting GLP-1 treatment for obesity.
However, at DomoMed Salud, we include it in the in-person programme because we understand weight management as part of a broader cardiometabolic assessment.
Many patients seeking treatment for obesity or overweight also have associated cardiovascular risk factors, including:
High blood pressure.
Dyslipidaemia.
Type 2 diabetes.
Metabolic syndrome.
Physical inactivity.
Obstructive sleep apnoea.
A family history of cardiovascular disease.
A 12-lead ECG can help detect:
Heart rhythm abnormalities.
Conduction blocks.
Signs of left ventricular hypertrophy.
Other findings that may be relevant when assessing cardiovascular risk.
The aim is not to make the process more complicated, but to make it safer and more complete.
At DomoMed Salud, we believe that medical weight-loss treatment should go beyond the number on the scales. It should assess the patient as a whole, especially when cardiometabolic risk factors are present.
What Does the Home Consultation in Madrid Involve?
The in-person Metabolic Care consultation follows a structured clinical protocol and takes place in the patient’s home.
The doctor travels with the necessary equipment, and the appointment lasts approximately 45 to 60 minutes.
During the consultation, a detailed medical history is taken, including:
Personal and family medical history.
Current medication.
Previous weight-loss attempts.
Lifestyle habits.
Relevant symptoms.
The patient’s goals.
The physical assessment includes:
Weight.
Height.
Body mass index calculation.
Waist circumference.
Blood pressure.
Heart rate.
A 12-lead ECG is also performed and subsequently analysed, with a report prepared by a cardiology specialist.
If the patient has recent blood test results covering the necessary parameters, these are reviewed during the consultation.
When no recent results are available, the doctor advises which tests should be requested before starting or continuing treatment.
Using all the available information, the doctor determines:
Whether pharmacological treatment is clinically indicated.
Which treatment option may be the most appropriate.
Which starting dose should be used.
When appropriate, the corresponding prescription is issued.
What Does the Online Consultation Involve?
The online Metabolic Care programme is designed for patients who do not live in Madrid or who prefer the convenience of a video consultation.
The initial appointment is carried out by video call and lasts approximately 45 minutes.
During the consultation, the doctor conducts a comprehensive clinical assessment, including:
Medical history.
Personal medical background.
Regular medication.
Weight.
Height.
Body mass index.
Waist circumference, when possible.
Review of blood test results.
Assessment of whether pharmacological treatment is appropriate.
Prescription when clinically indicated.
In this format, the physical measurements are taken by the patient with guidance from the doctor.
Patients are advised to have:
An up-to-date weight measurement.
A recent blood pressure reading when a home blood pressure monitor is available.
Recent blood test results.
A cardiology assessment and ECG are not routinely included in the online programme.
Patients with significant cardiovascular risk factors, cardiac symptoms or a history of cardiovascular disease may be advised to provide a recent ECG or arrange an additional assessment.
How Is the Medication Managed?
One of the most common concerns among patients starting treatment with semaglutide, tirzepatide or other weight-management medications is availability and continuity of supply.
With the patient’s express authorisation, DomoMed Salud can coordinate communication with a partner pharmacy to help check availability, arrange dispensing and, when possible, facilitate delivery of the prescribed medication.
Once the prescription has been issued, the partner pharmacy may contact the patient directly to confirm:
Availability.
Price.
Payment method.
Collection or delivery options.
This means that the patient does not have to manage the entire process alone or visit multiple pharmacies in search of the medication.
It is important to clarify that medication is not included in the price of the Metabolic Care programme.
The pharmacy invoices the patient directly according to:
The medication prescribed.
The dose.
Current pharmacy prices.
DomoMed Salud does not sell, store, dispense or transport medication.
Our role is medical and care-coordination based:
Assessing the patient.
Prescribing treatment when indicated.
Providing clinical follow-up.
Facilitating communication with the partner pharmacy when the patient has given consent.
What Does the Monthly Follow-Up Include?
The Metabolic Care programme includes three monthly follow-up consultations after the initial assessment.
These appointments are carried out by video call and allow the doctor to assess:
Weight-loss progress.
Treatment tolerance.
Side effects.
Whether the dose needs to be adjusted.
Progress towards agreed goals.
The follow-up reviews areas such as:
Weight changes.
Digestive tolerance.
Nausea.
Vomiting.
Constipation.
Other side effects.
Adherence to treatment.
Eating habits.
Physical activity.
Blood pressure when relevant.
Questions about medication administration.
The need for dose adjustment.
Treatment continuity.
Between consultations, patients may record:
Weekly weight.
Dose administration.
Hydration.
Eating habits.
Physical activity.
Side effects.
General wellbeing.
This information gives the medical team a more realistic view of the patient’s progress and helps identify potential problems early.
After the first three months, patients who require continued treatment can join DomoMed Salud’s monthly follow-up plan.
This includes:
A monthly medical video consultation.
Dose adjustment when appropriate.
Prescription renewal when appropriate.
Review of treatment goals.
What Makes the Metabolic Care Programme Different?
DomoMed Salud’s Metabolic Care programme combines three key elements within one coordinated care pathway:
Medical assessment.
Clinical follow-up.
Convenience for the patient.
Integrated Cardiometabolic Assessment
The first distinguishing feature is the integrated cardiometabolic assessment, particularly within the in-person programme.
This includes a 12-lead ECG and cardiology report, allowing for a more comprehensive approach in patients with obesity, overweight or cardiovascular risk factors.
Coordination with Partner Pharmacies
The second distinguishing feature is coordination with partner pharmacies.
This can make it easier for patients to access the prescribed treatment and reduce unnecessary travel and administrative steps.
Structured Clinical Follow-Up
The third distinguishing feature is structured clinical follow-up.
This allows us to:
Support patients during the early stages of treatment.
Adjust the dose when appropriate.
Answer questions.
Identify side effects.
Help maintain long-term goals.
Weight management with GLP-1 medications should not be understood as an isolated solution.
It should form part of a comprehensive medical plan.
At DomoMed Salud, our aim is for patients to feel supported, safe and motivated throughout the process.
Losing weight is not only about the number on the scales.
It can also mean regaining confidence, improving health, feeling better and moving towards a healthier version of yourself.
Frequently Asked Questions
Is the Metabolic Care Programme Available Throughout Spain?
Yes.
The online programme is available to patients anywhere in Spain.
The in-person programme, including a home consultation and ECG, is available in Madrid and nearby municipalities.
How Much Does the Medication Cost?
Medication is not included in the programme price.
The cost depends on:
The medication prescribed.
The dose.
Current pharmacy prices.
The partner pharmacy invoices the patient directly for each dispensing.
Does DomoMed Guarantee Medication Availability?
No healthcare provider can guarantee the permanent availability of a medication, as this depends on pharmacy stock, distribution and market conditions.
However, DomoMed can help coordinate with a partner pharmacy to reduce administrative steps, confirm availability and support treatment continuity whenever possible.
Do I Have to Go to the Pharmacy in Person?
Not necessarily.
Once the prescription has been issued, and with your authorisation, DomoMed can facilitate communication with a partner pharmacy.
The pharmacy can then contact you directly to confirm:
Availability.
Price.
Dispensing options.
Depending on your location, stock and the conditions of the service, the pharmacy may provide information about collection or delivery.
Dispensing, invoicing and delivery are always the responsibility of the authorised pharmacy.
What Happens If I Experience Side Effects Between Consultations?
You will have access to medical follow-up to discuss concerns or report side effects.
Depending on the circumstances, the doctor may:
Adjust the dose.
Modify the treatment schedule.
Recommend supportive measures.
Bring the next follow-up consultation forward.
Can I Request an ECG If I Am an Online Patient?
Yes.
If you live in Madrid, you can request an ECG at home as an additional test.
If you live outside Madrid, we can advise you on how to arrange an ECG through your local healthcare provider and submit the results for review during the consultation.
Final Message
GLP-1 pharmacological treatment can be an effective medical tool for weight management.
However, its success depends largely on the context in which it is provided:
An appropriate clinical indication.
A complete initial assessment.
Effective treatment coordination.
Close medical follow-up over time.
At DomoMed Salud, we are committed to providing accessible, rigorous medical care based on the best available scientific evidence.
Our goal is to offer clear information and high-quality medical support to help you protect your health and the health of your loved ones.
The Metabolic Care programme is our way of supporting you from the initial consultation through to long-term maintenance, combining medical assessment, clinical follow-up and convenience.
Thank you for trusting DomoMed Salud.
The DomoMed Salud Team
Bibliography Note
Prepared in April 2026.
This content was developed using:
The European product information for Wegovy — semaglutide 2.4 mg.
Therapeutic frameworks from scientific societies specialising in obesity and cardiometabolic risk.
Reference materials from international health organisations.
Published results from the STEP clinical trial programme investigating semaglutide in obesity.
Research regarding the cardiovascular benefits of semaglutide in selected patients with overweight or obesity and established cardiovascular disease was also taken into account.
Medical Disclaimer
The information contained in this article is intended for informational and educational purposes only.
It does not replace an individual medical assessment.
Pharmacological treatments for weight management are prescription-only medicines and should only be used following a complete clinical assessment.
The indication for treatment, choice of medication, dose and duration must always be determined by a doctor.
If you have concerns about your weight, cardiometabolic risk or whether a particular treatment is appropriate for you, consult a doctor for a personalised assessment.
